Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Type 1 Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

Biochemical Tests

The investigators will perform blood tests in every participant.

DIAGNOSTIC_TEST

Osteodensitometry

The investigators will perform an osteodensitometry in every participant.

DIAGNOSTIC_TEST

Clinical Tests

The investigators perform the following clinical tests: vibration threshold test, monofilament test, chair rise test and timed up and go test in every participant.

DIAGNOSTIC_TEST

HR-QCT

The investigators will perform HR-QCT measurements of the proximal femur and tibia in every participant.

DIAGNOSTIC_TEST

HR-pQCT

The investigators will perform HR-pQCT measurements of the distal radius and distal tibia in every participant.

Trial Locations (1)

4031

Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

University Hospital Schleswig-Holstein

OTHER

collaborator

University Hospital, Basel, Switzerland

OTHER

lead

Christian Meier

OTHER

NCT03751839 - Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes | Biotech Hunter | Biotech Hunter